期刊文献+

前列地尔联合依帕司他和甲钴胺治疗2型糖尿病周围神经病变的临床研究 被引量:6

Clinical study of alprostadil combined with epalrestat and methylcobalamin in the treatment of type 2 diabetic peripheral neuropathy
原文传递
导出
摘要 目的探讨前列地尔联合依帕司他和甲钴胺治疗2型糖尿病周围神经病变的疗效。方法选择白银市第一人民医院2014年1月至2016年6月收治的2型糖尿病周围神经病变患者120例,采用随机数字表法分为两组。观察组64例采用前列地尔、依帕司他和甲钻胺联合治疗,对照组56例采用前列地尔、甲钴胺联合治疗,两组疗程均为4周。比较两组治疗前后血糖、临床症状、不良反应、神经传导速度等指标。结果治疗后两组空腹血糖、餐后2h血糖均明显下降(t=18.20、17.61、15.75、23.69,均P〈0.05);观察组腓肠神经传导速度、正中神经传导速度、尺神经传导速度均明显高于对照组(t=1.989、2.638、3.026、2.187、2.619、1.997,均P〈0.05);观察组治疗总有效率明显高于对照组(95.3%比82.1%,χ^2=4.54,P〈0.05);两组血糖及不良反应发生率差异均无统计学意义(t=0.267、0.176、0.695、0.658;χ^2=1.356,均P〉0.05)。结论前列地尔、依帕司他、甲钴胺联合治疗2型糖尿病周围神经病变的疗效良好。 Objective To study the effect of alprostadil combined with epalrestat and methylcobalamin in the treatment of type 2 diabetic peripheral neuropathy. Methods From January 2014 to June 2016,120 patients with type 2 diabetic peripheral neuropathy in the First People's Hospital of Baiyin were randomly divided into two groups according to the random number table method. 64 patients of the observation group were given the treatment of alprostadil, epalrestat combined with methylcobalamin. 56 patients of the control group were given the treatment of alprostadil and methylcobalamin. And the two groups were treated for 4 weeks. The blood glucose, clinical symptoms, adverse reaction, nerve conduction velocity index were compared between the two groups before and after treatment. Results The fasting blood glucose and 2 - hour postprandial blood glucose of the two groups after treatment were significantly decreased ( t = 18.20,17.61,15.75,23.69, all P 〈 0.05 ), and the conduction velocity of the common peroneal nerve, the median nerve and the ulnar nerve in the observation group were significantly higher than those in the control group (t = 1. 989,2. 638,3. 026,2. 187,2. 619,1. 997, all P 〈 0.05 ). The total effective rate of the observation group was significantly higher than that of the control group (95.3% vs. 82.1%, χ^2 = 4.54, P 〈 0.05 ). There were no statistically significant differences in the blood glucose and the incidence rate of adverse reactions between the two groups (t = O. 267,0. 176,0. 695,0. 658, χ^2 = 1. 356, all P 〉0.05 ). Conclusion Alprostadil combined with epalrestat and methylcobalamin in the treatment of type 2 diabetic peripheral neuropathy has good effect.
作者 王晓敏 沈利兰 何柏林 张立莹 苟爱芳 Wang Xiaomin;Shen Lilan;He Bailin;Zhang Liying;Gou Aifang.(Department of Endocrinology, the First People's Hospital of Baiyin ,Baiyin, Gansu 730900, Chin)
出处 《中国基层医药》 CAS 2018年第13期1700-1703,共4页 Chinese Journal of Primary Medicine and Pharmacy
关键词 糖尿病神经病变 前列地尔 依帕司他 甲钴胺 Diabetic neuropathies Alprostadil Epalrestat Methylcobalamin
  • 相关文献

参考文献6

二级参考文献62

  • 1章晓燕,刘芳,贾伟平.α-硫辛酸与糖尿病周围神经病变[J].国外医学(内分泌学分册),2005,25(4):262-264. 被引量:146
  • 2钟惠菊,韩秀云,方育川,谭少珍,高东初.PGE_1治疗糖尿病周围神经病变的初步观察[J].中华内分泌代谢杂志,1995,11(2):115-116. 被引量:64
  • 3廖二元 超楚生.内分泌学[M].北京:人民卫生出版社,2003.1557.
  • 4Doupis J, Lyons TE Wu S, et al. Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neu- ropathy [ J ]. Jclin Endocrinol Melab 2009 ;94 ( 6 ) :2157.
  • 5DCCT Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 1995 ;122:561 - 568.
  • 6Sullivan KA, Kim B,Feldrnan EL. Insulir-like growth factors in the peripheral nervous system [ J ]. Endocrinology 2008 ; 149 ( 12 ) : 5963.
  • 7Vyas AA, Patel HV, Frombolt SE, et al. Gangliosides arefunc- tiona nerve coil ligands for myelin-associated glyeoprotein (MAG) an inhibitor of nerve regeneration. Pore NatAcad Sci USA 2008 ; 99 : 8412 - 8417.
  • 8Chang S,Hypolite JA,Mohanan S,et al.Alteration of the PKC-mediated signaling pathway for smooth muscle contraction in obstruction-induced hypertrophy of the urinary bladder[J].Lab Invest,2009,89(7):823-832.
  • 9Donnan J,Ledger S.An update on the treatment and management of diabetic peripheral neuropathy[J].CANNT J,2007,16(4):32-36.
  • 10Head KA.Peripheral neuropathy:pathogenic mechanisms and altemative therapies[J].Altem Med Rev,2006,11 (4):294-329.

共引文献116

同被引文献62

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部